PT  - JOURNAL ARTICLE
AU  - T R Marten
AU  - G R Bourne
AU  - G S Miles
AU  - B Shuker
AU  - H D Rankine
AU  - V N Dutka
TI  - The metabolism of ICI 118,587, a partial agonist of beta 1-adrenoceptors, in mice, rats, rabbits, dogs, and humans.
DP  - 1984 Sep 01
TA  - Drug Metabolism and Disposition
PG  - 652--660
VI  - 12
IP  - 5
4099  - http://dmd.aspetjournals.org/content/12/5/652.short
4100  - http://dmd.aspetjournals.org/content/12/5/652.full
SO  - Drug Metab Dispos1984 Sep 01; 12
AB  - The absorption, metabolism, and excretion of 14C-labeled xamoterol (ICI 118,587) has been examined in mice, rats, rabbits, dogs, and humans. There was incomplete absorption by all species after oral administration, ranging from 9% by humans to 36% by dogs. Most of the absorbed radioactivity was eliminated within 24 hr of administration and the renal route predominated. Conjugates of the parent compound were the only observed metabolites in urine, the phenolic glucuronide being the principal animal metabolite and the phenol sulfate being the only human metabolite. There were marked interspecies variations in metabolite patterns and dogs were the only animal species in which the sulfate metabolite was detected. Comparison of the urinary metabolite patterns also showed higher output of the conjugates after oral administration than after intravenous administration, indicating that first pass metabolism was taking place. Little significant change in absorption or metabolism was seen over a range of oral doses; in rats, some saturation of the glucuronide-conjugating mechanism was observed but the sulfate-conjugating mechanism showed little, if any, diminished capacity at high dose levels in dogs. The use of fast atom bombardment mass spectroscopy for the determination of the molecular weight of conjugates is described.